Human Molecular Genetics, 2000, Vol. 9, No. 9 1357-1367
© 2000 Oxford University Press
Dystrophin and utrophin influence fiber type composition and post-synaptic membrane structure
Department of Human Anatomy and Genetics, University of Oxford, Oxford OX1 3QX, UK and 1Department of Human Genetics, Center for Gene Therapy, University of Michigan Medical School, Ann Arbor, MI 48109-0618, USA
The X-linked muscle wasting disease Duchenne muscular dystrophy is caused by the lack of dystrophin in muscle. Protein structure predictions, patient mutations, in vitro binding studies and transgenic and knockout mice suggest that dystrophin plays a mechanical role in skeletal muscle, linking the subsarcolemmal cytoskeleton with the extracellular matrix through its direct interaction with the dystrophin-associated protein complex (DAPC). Although a signaling role for dystrophin has been postulated, definitive data have been lacking. To identify potential non-mechanical roles of dystrophin, we tested the ability of various truncated dystrophin transgenes to prevent any of the skeletal muscle abnormalities associated with the double knockout mouse deficient for both dystrophin and the dystrophin-related protein utrophin. We show that restoration of the DAPC with Dp71 does not prevent the structural abnormalities of the post-synaptic membrane or the abnormal oxidative properties of utrophin/dystrophin-deficient muscle. In marked contrast, a dystrophin protein lacking the cysteine-rich domain, which is unable to prevent dystrophy in the mdx mouse, is able to ameliorate these abnormalities in utrophin/dystrophin-deficient mice. These experiments provide the first direct evidence that in addition to a mechanical role and relocalization of the DAPC, dystrophin and utrophin are able to alter both structural and biochemical properties of skeletal muscle. In addition, these mice provide unique insights into skeletal muscle fiber type composition.
+ To whom correspondence should be addressed at: Department of Molecular and Cellular Biochemistry, 410 Hamilton Hall, The Ohio State University, College of Medicine, 1645 Neil Avenue, Columbus, OH 43210, USA. Tel: +1 614 292 7043; Fax: +1 614 292 4118; Email: rafael.1@osu.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. V. Welser, J. E. Rooney, N. C. Cohen, P. B. Gurpur, C. A. Singer, R. A. Evans, B. A. Haines, and D. J. Burkin Myotendinous Junction Defects and Reduced Force Transmission in Mice that Lack {alpha}7 Integrin and Utrophin Am. J. Pathol., October 1, 2009; 175(4): 1545 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Tidball and M. Wehling-Henricks The role of free radicals in the pathophysiology of muscular dystrophy J Appl Physiol, April 1, 2007; 102(4): 1677 - 1686. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Rooney, J. V. Welser, M. A. Dechert, N. L. Flintoff-Dye, S. J. Kaufman, and D. J. Burkin Severe muscular dystrophy in mice that lack dystrophin and {alpha}7 integrin J. Cell Sci., June 1, 2006; 119(11): 2185 - 2195. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Judge, M. Haraguchiln, and J. S. Chamberlain Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex J. Cell Sci., April 15, 2006; 119(8): 1537 - 1546. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schmidt, T. Muenster, S. Wick, J. Forst, and H. J. Schmitt Onset and duration of mivacurium-induced neuromuscular block in patients with Duchenne muscular dystrophy Br. J. Anaesth., December 1, 2005; 95(6): 769 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Burkin, G. Q. Wallace, D. J. Milner, E. J. Chaney, J. A. Mulligan, and S. J. Kaufman Transgenic Expression of {alpha}7{beta}1 Integrin Maintains Muscle Integrity, Increases Regenerative Capacity, Promotes Hypertrophy, and Reduces Cardiomyopathy in Dystrophic Mice Am. J. Pathol., January 1, 2005; 166(1): 253 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shiao, A. Fond, B. Deng, M. Wehling-Henricks, M. E. Adams, S. C. Froehner, and J. G. Tidball Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking {alpha}- and {beta}1-syntrophins Hum. Mol. Genet., September 1, 2004; 13(17): 1873 - 1884. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Montana and J. T. Littleton Characterization of a hypercontraction-induced myopathy in Drosophila caused by mutations in Mhc J. Cell Biol., March 29, 2004; 164(7): 1045 - 1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Porter, A. P. Merriam, P. Leahy, B. Gong, J. Feuerman, G. Cheng, and S. Khanna Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy Hum. Mol. Genet., February 1, 2004; 13(3): 257 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wieneke, P. Heimann, S. Leibovitz, U. Nudel, and H. Jockusch Acute pathophysiological effects of muscle-expressed Dp71 transgene on normal and dystrophic mouse muscle J Appl Physiol, November 1, 2003; 95(5): 1861 - 1866. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Haslett, D. Sanoudou, A. T. Kho, R. R. Bennett, S. A. Greenberg, I. S. Kohane, A. H. Beggs, and L. M. Kunkel Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle PNAS, November 12, 2002; 99(23): 15000 - 15005. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Chamberlain Gene therapy of muscular dystrophy Hum. Mol. Genet., October 1, 2002; 11(20): 2355 - 2362. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gattenlohner, C. Schneider, C. Thamer, R. Klein, W. Roggendorf, F. Gohlke, C. Niethammer, S. Czub, A. Vincent, H.-K. Muller-Hermelink, et al. Expression of foetal type acetylcholine receptor is restricted to type 1 muscle fibres in human neuromuscular disorders Brain, June 1, 2002; 125(6): 1309 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Blake, A. Weir, S. E. Newey, and K. E. Davies Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle Physiol Rev, April 1, 2002; 82(2): 291 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Porter, S. Khanna, H. J. Kaminski, J. S. Rao, A. P. Merriam, C. R. Richmonds, P. Leahy, J. Li, W. Guo, and F. H. Andrade A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice Hum. Mol. Genet., February 1, 2002; 11(3): 263 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. van der Flier, I. Kuikman, D. Kramer, D. Geerts, M. Kreft, T. Takafuta, S. S. Shapiro, and A. Sonnenberg Different splice variants of filamin-B affect myogenesis, subcellular distribution, and determine binding to integrin {beta} subunits J. Cell Biol., January 21, 2002; 156(2): 361 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Royuela, G. Hugon, F. Rivier, J. A. Fehrentz, J. Martinez, R. Paniagua, and D. Mornet Variations in Dystrophin Complex in Red and White Caudal Muscles from Torpedo marmorata J. Histochem. Cytochem., July 1, 2001; 49(7): 857 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Burkin, G. Q. Wallace, K. J. Nicol, D. J. Kaufman, and S. J. Kaufman Enhanced Expression of the {alpha}7{beta}1 Integrin Reduces Muscular Dystrophy and Restores Viability in Dystrophic Mice J. Cell Biol., March 19, 2001; 152(6): 1207 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Chamberlain Muscular Dystrophy Meets the Gene Chip: New Insights into Disease Pathogenesis J. Cell Biol., December 11, 2000; 151(6): f43 - f46. [Full Text] [PDF] |
||||
![]() |
M. Sander, B. Chavoshan, S. A. Harris, S. T. Iannaccone, J. T. Stull, G. D. Thomas, and R. G. Victor Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy PNAS, November 16, 2000; (2000) 250379497. [Abstract] [Full Text] |
||||
![]() |
G. E. Crawford, J. A. Faulkner, R. H. Crosbie, K. P. Campbell, S. C. Froehner, and J. S. Chamberlain Assembly of the Dystrophin-Associated Protein Complex Does Not Require the Dystrophin Cooh-Terminal Domain J. Cell Biol., September 18, 2000; 150(6): 1399 - 1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Sweeney and E. R. Barton The dystrophin-associated glycoprotein complex: What parts can you do without? PNAS, December 5, 2000; 97(25): 13464 - 13466. [Full Text] [PDF] |
||||
![]() |
M. Sander, B. Chavoshan, S. A. Harris, S. T. Iannaccone, J. T. Stull, G. D. Thomas, and R. G. Victor Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy PNAS, December 5, 2000; 97(25): 13818 - 13823. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. van der Flier, I. Kuikman, D. Kramer, D. Geerts, M. Kreft, T. Takafuta, S. S. Shapiro, and A. Sonnenberg Different splice variants of filamin-B affect myogenesis, subcellular distribution, and determine binding to integrin {beta} subunits J. Cell Biol., January 21, 2002; 156(2): 361 - 376. [Abstract] [Full Text] [PDF] |
||||









